T37.1X2 Poisoning by antimycobacterial drugs, intentional self-harm

Name of the Condition

• Poisoning by antimycobacterial drugs, intentional self-harm

Summary

This condition involves intentional self-harm resulting from exposure to antimycobacterial medications, which are used to treat mycobacterial infections such as tuberculosis. It includes deliberate ingestion or administration of these drugs with the intent to cause harm, potentially leading to toxic reactions or overdose.

Causes

Intentional self-harm may result from deliberate overdose, self-administration of antimycobacterial drugs, or other intentional acts involving these medications. This can occur due to suicidal ideation, misuse, or attempts to self-poison.

Risk Factors

• History of mental health conditions or suicidal behavior.
• Access to antimycobacterial medications without supervision.
• Concurrent substance use or psychiatric disorders.
• Lack of social support or access to mental health resources.

Symptoms

• Gastrointestinal: Nausea, vomiting, abdominal pain.
• Neurological: Dizziness, confusion, seizures, or altered mental status.
• Dermatological: Rash, itching, or hypersensitivity reactions.
• Systemic: Organ toxicity (e.g., hepatic or renal), metabolic disturbances.

Diagnosis

Clinical assessment focuses on medication history, intent of exposure, and lab tests (e.g., drug levels, organ function). Toxicology screening confirms exposure, while psychiatric evaluation assesses self-harm risk. Imaging or other studies may evaluate organ damage.

Treatment Options

Management includes decontamination (if appropriate), supportive care (e.g., airway protection, fluid resuscitation), and specific antidotes if available. Psychiatric intervention and safety planning are critical. Long-term care may involve therapy or medication for underlying conditions.

Prognosis and Follow-Up

Prognosis depends on the dose, timing of care, and organ involvement. Follow-up includes monitoring for delayed toxicity and ongoing psychiatric support. Recovery may be prolonged, with risk of recurrence if underlying issues are unaddressed.

Complications

• Organ failure (e.g., hepatic, renal) from toxicity.
• Neurological damage or cognitive impairment.
• Psychiatric sequelae or recurrent self-harm.
• Long-term disability from organ injury.

Lifestyle & Prevention

• Secure storage of medications to limit access.
• Mental health support and crisis intervention resources.
• Education on safe medication handling and disposal.
• Regular psychiatric evaluations for at-risk individuals.

When to Seek Professional Help

Seek immediate care for suspected self-harm, especially with symptoms like altered mental status, severe gastrointestinal distress, or known exposure. Emergency services or a healthcare provider should be contacted promptly.

Tips for Medical Coders

Document intent clearly (e.g., self-harm, suicidal ideation) and specify the antimycobacterial drug involved. Include details on exposure circumstances, clinical findings, and management. Ensure alignment with clinical documentation to support code assignment.